A detailed history of Bank Of America Corp transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 33,056 shares of RGLS stock, worth $46,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,056
Holding current value
$46,608
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.8 $59,170 - $92,556
33,056 New
33,056 $59,000
Q4 2023

Feb 14, 2024

BUY
$1.21 - $1.44 $13 - $15
11 New
11 $0
Q4 2022

Feb 10, 2023

BUY
$1.17 - $1.85 $21 - $33
18 New
18 $0
Q2 2022

Aug 12, 2022

BUY
$1.6 - $3.4 $1,601 - $3,403
1,001 New
1,001 $2,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $20.6M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.